FHL1 as a prognostic biomarker and therapeutic target in acute promyelocytic leukaemia
Abstract Acute myeloid leukemia (AML) has a poor prognosis and high heterogeneity. Most cases of leukemias are caused by environmental factors interacting with the cell’s genetic material, but treatment is still dominated by cell cycle drugs. Therefore, there is an urgent need to find reliable bioma...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-01-01
|
| Series: | Discover Oncology |
| Online Access: | https://doi.org/10.1007/s12672-025-01738-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|